Top News
Basilea reports receipt of milestone payment based on first Cresemba® approval in Latin America
SBA Member, 19.07.2018
AC Immune Announces Price of USD 11.75 for Offerings and Issuance of up to 10 Million Common Shares
SBA Member, 19.07.2018
Novartis Kisqali® now first and only CDK4/6 inhibitor indicated in US as first-line therapy specifically for premenopausal women; and as initial therapy with fulvestrant in postmenopausal women
SBA Member, 18.07.2018
Novartis delivers solid growth in second quarter and continues transformation to a focused medicines company
SBA Member, 18.07.2018
AC Immune Announces Offerings and Issuance of up to 10 Million Common Shares
SBA Member, 18.07.2018
Crenezumab's Second Phase 3 Trial (CREAD 2) Fully Recruited - Updates on AC Immune's Pipeline and Technology Platforms to be presented at AAIC in Chicago
SBA Member, 17.07.2018
Van Leeuwenhoeck Issues Equity Research Note Highlighting Addex Investment Opportunity
SBA Member, 12.07.2018
Export sentiment still riding high – neither trade tensions nor Brexit cloud the outlook
Switzerland, 12.07.2018
Partners
Supported by:
